STAT Plus: In a first for RNA-modifying drugs, AstraZeneca partners with startup Accent Therapeutics
RAPHAEL LAFARGUE/ABACA/SIPA USA VIA AP
The deal may be the first partnership a pharmaceutical company has forged with a company using this technique for modifying RNA.
No hay comentarios:
Publicar un comentario